Skip to content

Effect of Matrices on Serum Fructose.

Effects of the Food Matrix on Serum Fructose Peaks

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05826717
Enrollment
23
Registered
2023-04-24
Start date
2022-12-15
Completion date
2024-12-20
Last updated
2025-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fructose Metabolism Disorder

Brief summary

Epidemiological evidence is accumulating that a high consumption of added sugars is associated with metabolic diseases such as non-alcoholic fatty liver disease and type 2 diabetes. Fructose, one of the principal added sugars, is believed to be the most disadvantageous sugar. Data from a large population-based cohort demonstrated that fructose intake from fruit juice and sugar-sweetened beverages, but not whole fruits, is associated with higher intrahepatic lipid content. A study in mice demonstrated that fast fructose exposure resulted in higher intrahepatic lipid content than slow fructose exposure. The food matrix, i.e. the complex spatial organisation of and interactions between nutrients, may account for the fast versus slow fructose exposure and subsequent health consequences. Therefore the investigators aim to investigate the role of the fructose matrices on serum fructose peaks. The investigators hypothesize that liquid fructose matrices will cause higher serum fructose peaks in comparison to solid fructose matrices. Objective: To quantify serum fructose peaks within 150 minutes following intake of fructose-containing matrices.

Interventions

OTHERApple

20g fructose in \[x\] g of apple

OTHERMashed apple

20g fructose in \[x\] g of mashed apple

20g fructose in \[x\] ml apple juice

OTHERFructose powder in water

20g fructose in \[x\] ml water

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

This study is an open-label, randomized, single meal, cross-over study in healthy individuals.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18 years. * Body mass index (BMI) ≥18.5 kg/m2 and \<25 kg/m2

Exclusion criteria

* Pregnancy. * Drugs and/or alcohol abuse. * Diagnosis of diabetes mellitus. * (History of) gastrointestinal and/or liver disease. * (History \[\< 5 years\] of) cancer (excluding basal cell carcinoma) * Physical stress one month prior to inclusion (i.e. post-surgery, trauma that requires medical treatment, bacterial/viral/fungal infection or extreme psychological stress). Symptoms of infection include: fever, (excessive) sweating & chills, cough, sore throat, shortness of breath, nasal congestion, diarrhea, vomiting, painful miction, redness/swelling, stomach ache, head ache, and stiff neck. * Unstable weight for 3 months prior to inclusion (i.e. 5% change in bodyweight) * Allergy to one of the used food products in the study. * Inability to provide written informed consent.

Design outcomes

Primary

MeasureTime frame
Change in serum fructose between peak and baselineTime points 0, 15, 30, 45, 60, 75, 90, 105, 120, 135 and 150 minutes following consumption of the food product.

Secondary

MeasureTime frameDescription
Blood pressureTime points 0, 15, 30, 45, 60, 75, 90, 105, 120, 135 and 150 minutes following consumption of the food product.Millimeter of mercury
Serum uric acidTime points 0, 15, 30, 45, 60, 75, 90, 105, 120, 135 and 150 minutes following consumption of the food product.Millimoles per liter

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026